Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease
Gayathri Nair Sekhar, Alice L. Fleckney, Sevda Tomova Boyanova, Huzefa Rupawala, Rachel Lo, Hao Wang, Doaa Boshra Farag, Khondaker Miraz Rahman, Martin Broadstock, Suzanne Reeves, Sarah Ann Thomas
This study shows that changes in BBB transporters OCT1, PMAT, and MATE1 in Alzheimer’s disease increase sensitivity to amisulpride.
Fluids and Barriers of the CNS · Dec 1, 2019Peer-reviewedNeuroscience